Show filters
Resources type
Filter by Resources type
Filter by Pathologies
Filter by Technologies
Filter by Instruments
30 result(s) found
Sort by:

Sebia and Metafora biosystems form strategic partnership to develop advanced in vitro diagnostics

Press release
Sep. 16, 2021

Sebia to acquire a minority stake in Metafora biosystems.

Multiple Myeloma clinical cases at diagnosis and monitoring according to latest IMWG recommendations

Aug. 11, 2021

Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD

Experience and recommendations of a Major Cancer Center to use HYDRASHIFT daratumumab

Aug. 09, 2021

Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.

Sebia Acquires Orgentec Diagnostika

Press release
Jun. 30, 2021

The strategic acquisition reinforces Sebia’s global leadership in specialty diagnostics.

The contribution of multimer analysis in the diagnosis of von Willebrand disease

Jun. 21, 2021

Educational Webinar with Dr. Annette BOWYER, Lead Biomedical Scientist

The importance of CDT-IFCC, marker of chronic alcohol excessive consumption

Jun. 10, 2021

Educational Webinar with M. Jean Deenmamode, IFCC Working Group Chair